Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO

Provided By PR Newswire

Last update: Apr 18, 2024

-- Application allowed with broad method claims that are Orange Book-listable --

-- Once issued, this will be Evofem's fifth patent covering Hormone-Free "In the Moment" Contraceptive Phexxi in the United States --